Skip to content

Safety and Efficacy of Zygomatic and Pterygoid Implants in Comparison

Safety and Efficacy of Zygomatic and Pterygoid Implants: A Non-Inferiority Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4wcdqxw
Enrollment
Unknown
Registered
2026-01-20
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth Loss

Interventions

This is a prospective controlled clinical trial using a split mouth design, doublo blinded, with 6 arm and randomized, with a follow up period of 12 months. The study aims to compare the clinical effe

Sponsors

Associação Salgado de Oliveira de Educação e Cultura
Lead Sponsor
Centro Universitário do Triângulo - UNITRI
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with an indication for full maxillary rehabilitation; Patients aged 18 years or older, of both sexes; Patients with sufficient bone availability for the placement of two zygomatic implants, two pterygoid implants, and two conventional anterior implants

Exclusion criteria

Exclusion criteria: Patients with uncontrolled systemic diseases; Smokers who consume more than 10 cigarettes per day; Patients using medications that may impair bone healing, such as bisphosphonates and corticosteroids

Design outcomes

Primary

MeasureTime frame
The primary outcome will be implant success rate, assessed through clinical evaluation. It is expected that no significant differences will be observed in success rates between the implants under investigation, and that any difference should not exceed 5% among the evaluated implants.

Secondary

MeasureTime frame
Implant stability will be measured by insertion torque and resonance frequency analysis. It is expected that no differences in clinical stability will be observed between the implants under investigation, and that any difference should not exceed 10 ISQ points among the evaluated implants;Peri-implant bone level will be assessed through radiographic analysis. It is expected that no differences in peri-implant bone levels will be observed between the implants under investigation, and that any difference should not exceed 0.5 mm among the evaluated implants;Peri-implant health will be assessed through clinical evaluation. It is expected that no differences in peri-implant health rates will be observed between the implants under investigation, and that any difference should not exceed 5% among the evaluated implant

Countries

Brazil

Contacts

Public ContactRoberto Pessoa

Centro Universitário do Triângulo - UNITRI

rp@inpes.com.br+55(34)4009-9000

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 7, 2026